Other analysts have also recently issued reports about the company. Royal Bank of Canada lowered their price objective on Surgery Partners from $70.00 to $65.00 and set an “outperform” rating on the stock in a research report on Tuesday, March 1st. JPMorgan Chase & Co. increased their target price on Surgery Partners from $50.00 to $55.00 and gave the company a “neutral” rating in a research note on Wednesday, March 2nd. Benchmark increased their price target on Surgery Partners from $65.00 to $72.00 in a report on Wednesday, May 4th. Zacks Investment Research cut Surgery Partners from a “hold” rating to a “sell” rating in a research report on Tuesday. Finally, SVB Leerink raised their price objective on Surgery Partners from $63.00 to $65.00 and gave the company an “outperform” rating in a research report on Wednesday, March 2nd. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, Surgery Partners presently has an average rating of “Hold” and an average target price of $60.11.
Shares of SGRY stock traded down $0.86 during trading hours on Thursday, reaching $42.16. 1,216,544 shares of the company’s stock were exchanged, compared to its average volume of 429,520. Surgery Partners has a fifty-two week low of $37.63 and a fifty-two week high of $69.58. The stock has a market capitalization of $3.79 billion, a P/E ratio of -79.55, a P/E/G ratio of 4.52 and a beta of 2.76. The business has a fifty day moving average price of $53.27 and a 200-day moving average price of $49.93. The company has a quick ratio of 1.65, a current ratio of 1.73 and a debt-to-equity ratio of 1.50.
In related news, CEO Jason Eric Evans sold 14,071 shares of the firm’s stock in a transaction dated Monday, February 28th. The shares were sold at an average price of $52.25, for a total transaction of $735,209.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider George Goodwin sold 25,525 shares of the firm’s stock in a transaction dated Thursday, April 21st. The stock was sold at an average price of $62.58, for a total transaction of $1,597,354.50. Following the sale, the insider now owns 57,990 shares of the company’s stock, valued at approximately $3,629,014.20. The disclosure for this sale can be found here. Insiders have sold 116,220 shares of company stock worth $6,300,372 over the last three months. 3.30% of the stock is owned by insiders.
Several institutional investors and hedge funds have recently bought and sold shares of the company. BlackRock Inc. increased its stake in shares of Surgery Partners by 1.0% in the first quarter. BlackRock Inc. now owns 2,280,249 shares of the company’s stock worth $125,528,000 after purchasing an additional 22,579 shares in the last quarter. Invesco Ltd. increased its stake in shares of Surgery Partners by 31.9% in the fourth quarter. Invesco Ltd. now owns 1,556,434 shares of the company’s stock worth $83,129,000 after purchasing an additional 376,600 shares in the last quarter. Victory Capital Management Inc. increased its stake in shares of Surgery Partners by 10.2% in the fourth quarter. Victory Capital Management Inc. now owns 1,372,328 shares of the company’s stock worth $73,296,000 after purchasing an additional 127,067 shares in the last quarter. Millennium Management LLC purchased a new position in shares of Surgery Partners in the third quarter worth about $34,884,000. Finally, State Street Corp increased its stake in shares of Surgery Partners by 2.0% in the fourth quarter. State Street Corp now owns 699,707 shares of the company’s stock worth $37,371,000 after purchasing an additional 13,861 shares in the last quarter.
About Surgery Partners (Get Rating)
Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.
- Get a free copy of the StockNews.com research report on Surgery Partners (SGRY)
- Carvana Insiders Buy Shares But Maybe You Shouldn’t
- Dutch Bros Gets Scalded By Inflation
- The S&P 500 Could Fall Another 28%
- Corning Stock is a Technology Value Play
- Wolverine Worldwide Is Ready To Rebound
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.